The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells.

Osteosarcoma (OS) is an aggressive bone malignancy commonly observed in children and adolescents. Sub-optimal therapy for years has irretrievably compromised the chances of OS patient survival; also, lack of extensive research on this rare disease has hindered therapeutic development. Cisplatin, a c...

Full description

Bibliographic Details
Main Authors: Sudeshna Mukherjee, Subhra Dash, K Lohitesh, Rajdeep Chowdhury
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5466322?pdf=render
_version_ 1819330637406928896
author Sudeshna Mukherjee
Subhra Dash
K Lohitesh
Rajdeep Chowdhury
author_facet Sudeshna Mukherjee
Subhra Dash
K Lohitesh
Rajdeep Chowdhury
author_sort Sudeshna Mukherjee
collection DOAJ
description Osteosarcoma (OS) is an aggressive bone malignancy commonly observed in children and adolescents. Sub-optimal therapy for years has irretrievably compromised the chances of OS patient survival; also, lack of extensive research on this rare disease has hindered therapeutic development. Cisplatin, a common anti-tumor drug, is currently an integral part of treatment regime for OS along with methotrexate and doxorubicin. However, toxicity issues associated with combination module impede OS therapy. Also, despite the proven benefits of cisplatin, acquisition of resistance remains a concern with cisplatin-based therapy. This prompted us to investigate the molecular effects of cisplatin exposure and changes associated with acquired resistance in OS cells. Cisplatin shock was found to activate MAPK signaling and autophagy in OS cells. An activation of JNK and autophagy acted as pro-survival strategy, while ERK1/2 triggered apoptotic signals upon cisplatin stress. A crosstalk between JNK and autophagy was observed. Maximal sensitivity to cisplatin was obtained with simultaneous inhibition of both autophagy and JNK pathway. Cisplatin resistant cells were further developed by repetitive drug exposure followed by clonal selection. The resistant cells showed an altered signaling circuitry upon cisplatin exposure. Our results provide valuable cues to possible molecular alterations that can be considered for development of improved therapeutic strategy against osteosarcoma.
first_indexed 2024-12-24T14:01:41Z
format Article
id doaj.art-27e34e43984a46c08272d2908b3a156e
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-24T14:01:41Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-27e34e43984a46c08272d2908b3a156e2022-12-21T16:52:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01126e017920310.1371/journal.pone.0179203The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells.Sudeshna MukherjeeSubhra DashK LohiteshRajdeep ChowdhuryOsteosarcoma (OS) is an aggressive bone malignancy commonly observed in children and adolescents. Sub-optimal therapy for years has irretrievably compromised the chances of OS patient survival; also, lack of extensive research on this rare disease has hindered therapeutic development. Cisplatin, a common anti-tumor drug, is currently an integral part of treatment regime for OS along with methotrexate and doxorubicin. However, toxicity issues associated with combination module impede OS therapy. Also, despite the proven benefits of cisplatin, acquisition of resistance remains a concern with cisplatin-based therapy. This prompted us to investigate the molecular effects of cisplatin exposure and changes associated with acquired resistance in OS cells. Cisplatin shock was found to activate MAPK signaling and autophagy in OS cells. An activation of JNK and autophagy acted as pro-survival strategy, while ERK1/2 triggered apoptotic signals upon cisplatin stress. A crosstalk between JNK and autophagy was observed. Maximal sensitivity to cisplatin was obtained with simultaneous inhibition of both autophagy and JNK pathway. Cisplatin resistant cells were further developed by repetitive drug exposure followed by clonal selection. The resistant cells showed an altered signaling circuitry upon cisplatin exposure. Our results provide valuable cues to possible molecular alterations that can be considered for development of improved therapeutic strategy against osteosarcoma.http://europepmc.org/articles/PMC5466322?pdf=render
spellingShingle Sudeshna Mukherjee
Subhra Dash
K Lohitesh
Rajdeep Chowdhury
The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells.
PLoS ONE
title The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells.
title_full The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells.
title_fullStr The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells.
title_full_unstemmed The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells.
title_short The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells.
title_sort dynamic role of autophagy and mapk signaling in determining cell fate under cisplatin stress in osteosarcoma cells
url http://europepmc.org/articles/PMC5466322?pdf=render
work_keys_str_mv AT sudeshnamukherjee thedynamicroleofautophagyandmapksignalingindeterminingcellfateundercisplatinstressinosteosarcomacells
AT subhradash thedynamicroleofautophagyandmapksignalingindeterminingcellfateundercisplatinstressinosteosarcomacells
AT klohitesh thedynamicroleofautophagyandmapksignalingindeterminingcellfateundercisplatinstressinosteosarcomacells
AT rajdeepchowdhury thedynamicroleofautophagyandmapksignalingindeterminingcellfateundercisplatinstressinosteosarcomacells
AT sudeshnamukherjee dynamicroleofautophagyandmapksignalingindeterminingcellfateundercisplatinstressinosteosarcomacells
AT subhradash dynamicroleofautophagyandmapksignalingindeterminingcellfateundercisplatinstressinosteosarcomacells
AT klohitesh dynamicroleofautophagyandmapksignalingindeterminingcellfateundercisplatinstressinosteosarcomacells
AT rajdeepchowdhury dynamicroleofautophagyandmapksignalingindeterminingcellfateundercisplatinstressinosteosarcomacells